Cargando…

Mouse Ataxin-3 Functional Knock-Out Model

Spinocerebellar ataxia 3 (SCA3) is a genetic disorder resulting from the expansion of the CAG repeats in the ATXN3 gene. The pathogenesis of SCA3 is based on the toxic function of the mutant ataxin-3 protein, but the exact mechanism of the disease remains elusive. Various types of transgenic mouse m...

Descripción completa

Detalles Bibliográficos
Autores principales: Switonski, Pawel M., Fiszer, Agnieszka, Kazmierska, Katarzyna, Kurpisz, Maciej, Krzyzosiak, Wlodzimierz J., Figiel, Maciej
Formato: Texto
Lenguaje:English
Publicado: Humana Press Inc 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044828/
https://www.ncbi.nlm.nih.gov/pubmed/20945165
http://dx.doi.org/10.1007/s12017-010-8137-3
_version_ 1782198783186042880
author Switonski, Pawel M.
Fiszer, Agnieszka
Kazmierska, Katarzyna
Kurpisz, Maciej
Krzyzosiak, Wlodzimierz J.
Figiel, Maciej
author_facet Switonski, Pawel M.
Fiszer, Agnieszka
Kazmierska, Katarzyna
Kurpisz, Maciej
Krzyzosiak, Wlodzimierz J.
Figiel, Maciej
author_sort Switonski, Pawel M.
collection PubMed
description Spinocerebellar ataxia 3 (SCA3) is a genetic disorder resulting from the expansion of the CAG repeats in the ATXN3 gene. The pathogenesis of SCA3 is based on the toxic function of the mutant ataxin-3 protein, but the exact mechanism of the disease remains elusive. Various types of transgenic mouse models explore different aspects of SCA3 pathogenesis, but a knock-in humanized mouse has not yet been created. The initial aim of this study was to generate an ataxin-3 humanized mouse model using a knock-in strategy. The human cDNA for ataxin-3 containing 69 CAG repeats was cloned from SCA3 patient and introduced into the mouse ataxin-3 locus at exon 2, deleting it along with exon 3 and intron 2. Although the human transgene was inserted correctly, the resulting mice acquired the knock-out properties and did not express ataxin-3 protein in any analyzed tissues, as confirmed by western blot and immunohistochemistry. Analyses of RNA expression revealed that the entire locus consisting of human and mouse exons was expressed and alternatively spliced. We detected mRNA isoforms composed of exon 1 spliced with mouse exon 4 or with human exon 7. After applying 37 PCR cycles, we also detected a very low level of the correct exon 1/exon 2 isoform. Additionally, we confirmed by bioinformatic analysis that the structure and power of the splicing site between mouse intron 1 and human exon 2 (the targeted locus) was not changed compared with the native mouse locus. We hypothesized that these splicing aberrations result from the deletion of further splicing sites and the presence of a strong splicing site in exon 4, which was confirmed by bioinformatic analysis. In summary, we created a functional ataxin-3 knock-out mouse model that is viable and fertile and does not present a reduced life span. Our work provides new insights into the splicing characteristics of the Atxn3 gene and provides useful information for future attempts to create knock-in SCA3 models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12017-010-8137-3) contains supplementary material, which is available to authorized users.
format Text
id pubmed-3044828
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Humana Press Inc
record_format MEDLINE/PubMed
spelling pubmed-30448282011-04-04 Mouse Ataxin-3 Functional Knock-Out Model Switonski, Pawel M. Fiszer, Agnieszka Kazmierska, Katarzyna Kurpisz, Maciej Krzyzosiak, Wlodzimierz J. Figiel, Maciej Neuromolecular Med Original Paper Spinocerebellar ataxia 3 (SCA3) is a genetic disorder resulting from the expansion of the CAG repeats in the ATXN3 gene. The pathogenesis of SCA3 is based on the toxic function of the mutant ataxin-3 protein, but the exact mechanism of the disease remains elusive. Various types of transgenic mouse models explore different aspects of SCA3 pathogenesis, but a knock-in humanized mouse has not yet been created. The initial aim of this study was to generate an ataxin-3 humanized mouse model using a knock-in strategy. The human cDNA for ataxin-3 containing 69 CAG repeats was cloned from SCA3 patient and introduced into the mouse ataxin-3 locus at exon 2, deleting it along with exon 3 and intron 2. Although the human transgene was inserted correctly, the resulting mice acquired the knock-out properties and did not express ataxin-3 protein in any analyzed tissues, as confirmed by western blot and immunohistochemistry. Analyses of RNA expression revealed that the entire locus consisting of human and mouse exons was expressed and alternatively spliced. We detected mRNA isoforms composed of exon 1 spliced with mouse exon 4 or with human exon 7. After applying 37 PCR cycles, we also detected a very low level of the correct exon 1/exon 2 isoform. Additionally, we confirmed by bioinformatic analysis that the structure and power of the splicing site between mouse intron 1 and human exon 2 (the targeted locus) was not changed compared with the native mouse locus. We hypothesized that these splicing aberrations result from the deletion of further splicing sites and the presence of a strong splicing site in exon 4, which was confirmed by bioinformatic analysis. In summary, we created a functional ataxin-3 knock-out mouse model that is viable and fertile and does not present a reduced life span. Our work provides new insights into the splicing characteristics of the Atxn3 gene and provides useful information for future attempts to create knock-in SCA3 models. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s12017-010-8137-3) contains supplementary material, which is available to authorized users. Humana Press Inc 2010-10-14 2011 /pmc/articles/PMC3044828/ /pubmed/20945165 http://dx.doi.org/10.1007/s12017-010-8137-3 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original Paper
Switonski, Pawel M.
Fiszer, Agnieszka
Kazmierska, Katarzyna
Kurpisz, Maciej
Krzyzosiak, Wlodzimierz J.
Figiel, Maciej
Mouse Ataxin-3 Functional Knock-Out Model
title Mouse Ataxin-3 Functional Knock-Out Model
title_full Mouse Ataxin-3 Functional Knock-Out Model
title_fullStr Mouse Ataxin-3 Functional Knock-Out Model
title_full_unstemmed Mouse Ataxin-3 Functional Knock-Out Model
title_short Mouse Ataxin-3 Functional Knock-Out Model
title_sort mouse ataxin-3 functional knock-out model
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3044828/
https://www.ncbi.nlm.nih.gov/pubmed/20945165
http://dx.doi.org/10.1007/s12017-010-8137-3
work_keys_str_mv AT switonskipawelm mouseataxin3functionalknockoutmodel
AT fiszeragnieszka mouseataxin3functionalknockoutmodel
AT kazmierskakatarzyna mouseataxin3functionalknockoutmodel
AT kurpiszmaciej mouseataxin3functionalknockoutmodel
AT krzyzosiakwlodzimierzj mouseataxin3functionalknockoutmodel
AT figielmaciej mouseataxin3functionalknockoutmodel